🇺🇸 FDA
Company

Indivior

Indivior Pharmaceuticals

INDV pharma USA

Quick answer

Indivior is a pharma company (INDV) headquartered in NORTH CHESTERFIELD, VA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Intranasal challenge drug

Heroin Dependence

Phase 3 · small_molecule · completed

1 trials project

RBP-6000

Opioid Use Disorder

Phase 3 · small_molecule · completed

4 trials project

RBP-7000

Schizophrenia

Phase 3 · small_molecule · completed

5 trials project

SUBLOCADE

Opioid Use Disorder

Phase 3 · small_molecule · terminated

2 trials project

SUBOXONE

Opioid Dependence

Phase 3 · small_molecule · completed

1 trials project

SUBOXONE sublingual film

Opioid Use Disorder

Phase 3 · small_molecule · completed

1 trials project

Arbaclofen Placarbil

Alcohol Use Disorder

Phase 2 · small_molecule · completed

1 trials project

Buprenorphine

Opioid Use Disorder

Phase 2 · small_molecule · completed

1 trials project

Buprenorphine hydrochloride marketed sublingual tablet (Subutex)

Opioid Dependency

Phase 2 · small_molecule · completed

1 trials project

Buprenorphine soluble film

Opioid-related Disorders

Phase 2 · small_molecule · completed

1 trials project

Buprenorphine/naloxone Film Strip

Opioid-Related Disorders

Phase 2 · small_molecule · completed

1 trials project

INDV-2000

Opioid Use Disorder

Phase 2 · small_molecule · completed

1 trials project

INDV-6001

Moderate to Severe Opioid Use Disorder

Phase 2 · small_molecule · completed

1 trials project

RBP-6000

Opioid Related Disorder

Phase 2 · small_molecule · completed

1 trials project

RBP-6300

Opioid Related Disorder

Phase 2 · small_molecule · completed

1 trials project

RBP-8000 100 mg

Opioid Dependence

Phase 2 · small_molecule · completed

1 trials project

Risperidone

Schizophrenia

Phase 2 · small_molecule · completed

1 trials project

XP19986 CR

GERD

Phase 2 · small_molecule · completed

1 trials project

Arbaclofen Placarbil SR

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

Buprenorphine Injectable Solution - Part A

Healthy

Phase 1 · small_molecule · completed

1 trials project

INDV-2000

Opioid Dependence

Phase 1 · small_molecule · completed

1 trials project

INDV-2000

Healthy

Phase 1 · small_molecule · completed

1 trials project

INDV-6200

Opioid-use Disorder

Phase 1 · small_molecule · completed

1 trials project

[14C]IDV184001AN

Opioid Use Disorder

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

nalmefene hydrochloride

REVEX

Patents (8)

patent

US 12290596

Compositions and methods for the treatment of opioid overdose

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11839611

Buprenorphine dosing regimens

Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11712475

Sustained delivery formulations of risperidone compound

Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11135216

Sublingual and buccal film compositions

Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11110093

Sustained release small molecule drug formulation

Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11013809

Sustained delivery formulations of risperidone compound

Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11000520

Buprenorphine dosing regimens

Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10654842

Dopamine D3 receptor antagonist compounds

Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)